Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 2536 in Various Solid Tumors (EORTC 90061)
NCT00526149Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Jul 2007
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BI-2536 in breast cancer, endometrial cancer (EC), head and neck cancer (HNC), melanoma, ovarian cancer, sponsored by European Organisation for Research and Treatment of Cancer. Started Jul 2007; status: completed.
02
Drugs
BI-2536
03
Conditions
breast cancerendometrial cancer (EC)head and neck cancer (HNC)melanomaovarian cancer
Beyond the preview
Go deeper on NCT00526149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00526149.